Search research articles
Contact Us
Filters
Showing results (121-130 of 10,653) with videos related to
Page
of 1,066
Sort By:
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Carlos J Madrid-Navarro, Rosa Sanchez-Galvez, Antonio Martinez-Nicolas, et al.
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms in Critical Illness - A Role of Hyperoxia-Induced Lung Injury
Alexander Czachor, Zachary Krueger, Young Cho, et al.
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on Innate Immunity
Viola Dengler, Kristin Westphalen, Michael Koeppen
Current Pharmaceutical Design
|
June 2, 2015
Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs
Jin Woo Park, Sun Jin Kim, Dong Sup Kwag, et al.
Current Pharmaceutical Design
|
June 6, 2015
Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
Bart A Ellenbroek, Bibinaz Ghiabi
Current Pharmaceutical Design
|
June 20, 2015
Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
Marine Mondino, Jerome Brunelin, Ulrich Palm, et al.
Current Pharmaceutical Design
|
June 20, 2015
Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
Gary Hulse, Erin Kelty, Sean Hood, et al.
Current Pharmaceutical Design
|
June 20, 2015
Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Letizia Bossini, Anna Coluccia, Ilaria Casolaro, et al.
Current Pharmaceutical Design
|
August 19, 2016
Editorial (Thematic Issue: Current and Perspective Therapeutic Strategies for Alzheimer's Disease)
Antonio Palumbo Piccionello, Francesco Cappello
Current Pharmaceutical Design
|
March 17, 2018
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
Maria Luz Fernandez, Minu Sara Thomas, Bruno S Lemos, et al.
Page
of 1,066
Search research articles
Search
Showing results (121-130 of 10,653) with videos related to
Sort By:
Page
of 1,066
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Carlos J Madrid-Navarro, Rosa Sanchez-Galvez, Antonio Martinez-Nicolas, et al.
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms in Critical Illness - A Role of Hyperoxia-Induced Lung Injury
Alexander Czachor, Zachary Krueger, Young Cho, et al.
Current Pharmaceutical Design
|
July 7, 2015
Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on Innate Immunity
Viola Dengler, Kristin Westphalen, Michael Koeppen
Current Pharmaceutical Design
|
June 2, 2015
Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs
Jin Woo Park, Sun Jin Kim, Dong Sup Kwag, et al.
Current Pharmaceutical Design
|
June 6, 2015
Do Histamine receptor 3 antagonists have a place in the therapy for schizophrenia?
Bart A Ellenbroek, Bibinaz Ghiabi
Current Pharmaceutical Design
|
June 20, 2015
Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions
Marine Mondino, Jerome Brunelin, Ulrich Palm, et al.
Current Pharmaceutical Design
|
June 20, 2015
Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
Gary Hulse, Erin Kelty, Sean Hood, et al.
Current Pharmaceutical Design
|
June 20, 2015
Off-Label Trazodone Prescription: Evidence, Benefits and Risks
Letizia Bossini, Anna Coluccia, Ilaria Casolaro, et al.
Current Pharmaceutical Design
|
August 19, 2016
Editorial (Thematic Issue: Current and Perspective Therapeutic Strategies for Alzheimer's Disease)
Antonio Palumbo Piccionello, Francesco Cappello
Current Pharmaceutical Design
|
March 17, 2018
TA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome
Maria Luz Fernandez, Minu Sara Thomas, Bruno S Lemos, et al.
Page
of 1,066